Skip to search boxSkip to navigationSkip to main content

Idiopathic dilated cardiomyopathy

  • Catherine E. Cooke
    ,
  • Michael D. Greenberg
    ,
  • ,
  • Kenneth Mishark
    ,
  • Masato Odawara
    ,
  • Kamejiro Yamashita
  • University of Sciences in Philadelphia
    ,
  • Georgetown University
    ,
  • Tulane University
    ,
  • United States Air Force Academy
    ,
  • University of Tsukuba
    ,
  • University of Texas MD Anderson Cancer Center
Scholary Output:
Contribution to journal
Letter
Research
Peer-review

Open access

Abstract

To the Editor: Dec and Fuster (Dec. 8 issue)1 categorized the use of beta-blockers in patients with idiopathic dilated cardiomyopathy as investigational. There is now sufficient evidence to support their use as adjunctive therapy. Numerous clinical trials have evaluated the use of beta-blockers in conjunction with angiotensin-converting—enzyme inhibitors, nitrates, diuretics, and digoxin in patients with idiopathic dilated cardiomyopathy and have found improvements in ejection fraction, cardiac index, and New York Heart Association class and a decreased number of hospital admissions and cardiac transplantations.2—4 However, there have been trials5,6 that did not show such improvements. This is probably because.

Publication Information

Output type

Scholary Output:
Contribution to journal
Letter
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1384-1386 (3 pages)

Journal (Volume, Issue Number)

New England Journal of Medicine (Volume 332, Issue 20)

Publication milestones

  • Published - 05/18/1995

Publication status

Published - 05/18/1995

ISSN

0028-4793

Publication IDs

  • Scopus: 0029647395
  • PubMed: 7772174

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.11
Fractional count
8
Fractional count
0.89
Fractional count
1
Fractional count
1